spacer
home > epc > spring 2002 > the importance of market research in patient recruitmen
PUBLICATIONS
European Pharmaceutical Contractor

The Importance of Market Research in Patient Recruitmen

Patient recruitment and enrolment are destined to become more challenging as the number of clinical studies grows. There are presently an estimated 50,000 to 60,000 ongoing clinical trials in the US alone (1), and there is every reason to expect this figure to increase based on the rise in R&D expenditures; the number of compounds in the pipeline; the growing number of patients per new drug application (NDA); and the more complex and global nature of trials. Growth is likely to be accompanied by a rise in directly competitive clinical trials, with many seeking access to the same investigators. In addition, there are bound to be more studies aimed at testing new compounds in special populations, which will yield a marketing advantage to the innovator if the studies prove successful.

The traditional patient recruitment model has centred around sponsors' reliance on proven investigators who promise to recruit the agreed upon number of patients from their own resources. In the past, this approach was generally successful as there were far fewer trials than there are presently. Today, a sought-after investigator is likely to have already used an in-house patient database to enrol several ongoing competitive trials, so that investigator may have exhausted his or her supply of potentially qualified patients for new trials. This reality is reflected in the fact that 78 per cent of today's clinical trials fail to meet patient enrolment deadlines (2).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Diana Anderson, PhD, President & Chief Executive Officer at Rheumatology Research International

Dr Diana Anderson is President and Chief Executive Officer at Rheumatology Research International, a comprehensive rheumatology provider to the clinical trials industry, based in Dallas, Texas. Diana oversees the clinical trial management services of over 50 affiliated private practice and academic investigator sites across the US and Canada.

She is well published in the area of arthritis and patient recruitment and is the author of two books: 50 Ways to Cope with Arthritis and A Guide to Patient Recruitment: Today's Best Practices and Proven Strategies. She is a Consultant in these areas to the pharmaceutical industry and performs numerous lectures in the areas of SMOs and patient recruitment.

spacer
Dr Diana Anderson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Entry now open for the PPMA Group Industry Awards 2019

The 2019 PPMA Group Industry Awards will be held at the National Conference Centre (NEC), Birmingham, on the evening of the first day of the PPMA Total Show 2019 Tuesday, 1 October 2019. 
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement